Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology.

Surabhi RanjanNebojša SkorupanXiaobu YeAnanyaa SivakumarOlga YankulinaDavid KamsonStuart A GrossmanOmar DzayeMatthias Holdhoff

Published in: Neuro-oncology practice (2019)

In this cross-sectional online survey we found that among neuro-oncology experts in the United States in 2017, BEV is predominantly utilized in select patients with rGBM, and is only rarely used in a small subgroup of patients with newly diagnosed GBM for control of edema. The low response rate may have introduced a nonresponse bias.

Keyphrases

cross sectional
newly diagnosed
palliative care
social media
health information
phase iii